Table 2 Details of cardiovascular events.

From: Xanthine oxidase inhibitors are associated with reduced risk of cardiovascular disease

 

Number of patients

All

XOI

+

Congestive and acute heart failure

29

17

12

Cerebral infarction

18

11

7

Myocardial infarction

12

9

3

Angina pectoris

9

5

4

Aortic disease

6

4

2

Cerebral hemorrhage

4

4

0

Subarachnoid hemorrhage

3

3

0

Arrhythmia

2

2

0

Chronic arteriosclerosis obliterans

2

2

0

Sudden death

1

1

0

Total

86

58

28

  1. XOI xanthine oxidase inhibitor.